GoHealth, Inc. (GOCO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
GOCO currently has 16.2M outstanding shares. with significant dilution risk as 80.8M authorized shares could dilute existing holders by 498.1%. The company has significantly diluted shareholders by 60.6% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 31, 2026 |
10-K filing | 16.2M shares outstanding |
16M | 81M |
| Dec 16, 2025 |
S-3 filing: This S-3 filing from 2025-12-16 discusses the potential offering of Class A common stock by a selling stockholder, outlining various methods of sale including direct sales to institutional investors, sales through underwriters or agents, derivative transactions, and delayed delivery contracts. It also describes potential stabilization activities by underwriters and the possibility of market making in the shares. |
16M | 81M |
| Nov 26, 2025 |
S-3/A filing: This S-3/A filing from 2025-11-26 relates to the potential offering of Class A common stock by selling stockholders, involving various methods such as direct sales, sales through underwriters, derivative transactions, and delayed delivery contracts. |
16M | 81M |
| Nov 17, 2025 |
S-3 filing: This S-3 filing from 2025-11-17 discusses the potential offering of Class A common stock by selling stockholders, outlining various methods of sale, including direct sales, sales through underwriters or agents, and derivative transactions. |
16M | 81M |
| Aug 12, 2025 |
10-Q filing | 16.0M shares outstanding |
16M | 81M |
| Aug 07, 2025 |
8-K filing: GoHealth, Inc. issued 4,766,219 shares of Class A common stock to lenders as consideration for amendments to the Existing Credit Agreement. |
10M | 81M |
| May 16, 2025 |
10-Q filing | 10.4M shares outstanding |
10M | 81M |
| Feb 27, 2025 |
10-K filing | 10.0M shares outstanding |
10M | 81M |
| Nov 07, 2024 |
10-Q filing | 10.1M shares outstanding |
10M | 81M |
| Aug 08, 2024 |
10-Q filing | 10.0M shares outstanding |
10M | 81M |
| May 09, 2024 |
10-Q filing | 9.7M shares outstanding |
9.7M | 81M |
| Mar 14, 2024 |
10-K filing | 9.3M shares outstanding |
9.3M | 81M |
| Nov 09, 2023 |
10-Q filing | 9.5M shares outstanding |
9.5M | 81M |
| Aug 10, 2023 |
10-Q filing | 9.1M shares outstanding |
9.1M | 81M |
| May 09, 2023 |
10-Q filing | 9.0M shares outstanding |
9M | 81M |
| Mar 23, 2023 |
10-K filing | 8.4M shares outstanding |
8.4M | 81M |
| Nov 14, 2022 |
10-Q filing | 132.4M shares outstanding |
130M | 81M |
| Aug 16, 2022 |
10-Q filing | 124.4M shares outstanding |
120M | 81M |
| May 10, 2022 |
10-Q filing | 116.2M shares outstanding |
120M | 81M |
| Mar 16, 2022 |
10-K filing | 106.0M shares outstanding |
110M | 81M |
| Nov 10, 2021 |
10-Q filing | 113.9M shares outstanding |
110M | 81M |
| Aug 12, 2021 |
10-Q filing | 114.6M shares outstanding |
110M | 81M |
| May 13, 2021 |
10-Q filing | 92.3M shares outstanding |
92M | 81M |
| Mar 16, 2021 |
10-K filing | 98.4M shares outstanding |
98M | 81M |
| Nov 13, 2020 |
10-Q filing | 84.2M shares outstanding |
84M | 81M |
| Aug 20, 2020 |
10-Q filing | 237.9M shares outstanding |
240M | 81M |
| Jul 08, 2020 |
S-1/A filing: This S-1/A filing describes a proposed offering where the company intends to use the net proceeds to purchase LLC Interests and pay cash to Blocker Shareholders. |
N/A | 81M |
| Jul 06, 2020 |
S-1/A filing: This S-1/A filing details the underwriting agreement for GoHealth, Inc.'s IPO, involving the issuance of Class A and Class B common stock, with Goldman Sachs, BofA Securities, and Morgan Stanley acting as representatives for the underwriters. |
N/A | 0 |
| Jun 19, 2020 |
S-1 filing: This S-1 filing outlines the initial public offering of Class A common stock, with proceeds used to purchase LLC Interests and pay cash to Blocker Shareholders, along with details of a Tax Receivable Agreement. |
N/A | 0 |